Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorBiagetti Biagetti, Betina
dc.contributor.authorSimó Canonge, Rafael
dc.date.accessioned2022-11-03T13:25:42Z
dc.date.available2022-11-03T13:25:42Z
dc.date.issued2022-08-05
dc.identifier.citationBiagetti B, Simò R. Pituitary Apoplexy: Risk Factors and Underlying Molecular Mechanisms. Int J Mol Sci. 2022 Aug 5;23(15):8721.
dc.identifier.issn1422-0067
dc.identifier.urihttps://hdl.handle.net/11351/8388
dc.descriptionApoplexy; Growth factors; Matrix metalloproteinase
dc.description.abstractPituitary apoplexy is a rare syndrome, graded from asymptomatic subclinical apoplexy to a life-threatening condition due to pituitary ischemia or haemorrhage of an enlarged pituitary gland. The risk factors and the molecular underlying mechanisms are yet to be elucidated. We provide an overview of the general concepts, the potential factors associated with pituitary adenoma susceptibility for apoplectic events and the molecular mechanisms that could be involved such as HIF-1α/VEGF pathways and metalloproteinases activation, among others. The knowledge of the molecular mechanisms that could participate in the pathogenesis of pituitary apoplexy is crucial to advancement in the identification of future diagnostic tools and therapeutic targets in this rare but sometimes fatal condition.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesInternational Journal of Molecular Sciences;23(15)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectHipòfisi - Necrosi
dc.subjectMalalties cerebrovasculars - Factors de risc
dc.subjectAdenoma
dc.subject.meshPituitary Apoplexy
dc.subject.mesh/complications
dc.subject.meshRisk Factors
dc.subject.meshAdenoma
dc.titlePituitary Apoplexy: Risk Factors and Underlying Molecular Mechanisms
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/ijms23158721
dc.subject.decsapoplejía hipofisaria
dc.subject.decs/complicaciones
dc.subject.decsfactores de riesgo
dc.subject.decsadenoma
dc.relation.publishversionhttps://doi.org/10.3390/ijms23158721
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliationUnitat de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid35955859
dc.identifier.wos000838924200001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record